Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Axis NIFTY Healthcare ETF Growth
+22.44%
3Y annualised
-0.09% 1D
NAV: 16 Jul '26
₹167.83
Min. for SIP
Not Supported
Fund size (AUM)
₹23.87 Cr
Expense ratio
0.44%
Rating
--
Holdings (22)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 18.12% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 8.21% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 7.72% |
| Divi's Laboratories Ltd | Healthcare | Equity | 7.68% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 7.60% |
| Cipla Ltd | Healthcare | Equity | 7.58% |
| Laurus Labs Ltd | Healthcare | Equity | 5.42% |
| Lupin Ltd | Healthcare | Equity | 5.40% |
| Fortis Healthcare Ltd | Healthcare | Equity | 4.58% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 4.45% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 4.01% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 3.05% |
| Alkem Laboratories Ltd | Healthcare | Equity | 2.99% |
| Biocon Ltd | Healthcare | Equity | 2.74% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.65% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 2.56% |
| Ipca Laboratories Ltd | Healthcare | Equity | 2.17% |
| Abbott India Ltd | Healthcare | Equity | 1.22% |
| Piramal Pharma Ltd | Healthcare | Equity | 0.96% |
| Syngene International Ltd | Healthcare | Equity | 0.77% |
| Others CBLO | Unspecified | CBLO | 0.08% |
| Net Receivables | Unspecified | Net Receivables | 0.03% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +12.1% | +22.4% | +13.3% | +14.4% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 16 | 9 | 5 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
NMNandik MallikMar 2026 - PresentView details
NM
Nandik Mallik
Mar 2026 - Present
View details
RGRohit GautamMar 2026 - PresentView details
RG
Rohit Gautam
Mar 2026 - Present
View details
About Axis NIFTY Healthcare ETF Growth
Axis NIFTY Healthcare ETF Growth is a Equity Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 04 Sep 2009. Nandik Mallik is the Current Fund Manager of Axis NIFTY Healthcare ETF Growth fund. The fund currently has an Asset Under Management(AUM) of ₹3,56,814 Cr and the Latest NAV as of 16 Jul 2026 is ₹167.83.
The Axis NIFTY Healthcare ETF Growth is rated Very High risk.
;
Investment Objective
The scheme seeks to provide returns before expenses that closely correspond to the total returns of the NIFTY Healthcare Index subject to tracking errors.
Fund benchmarkNIFTY Healthcare Total Return Index.
Fund house
Rank (total assets)#7 in India
Total AUM₹3,56,814.22 Cr
Date of Incorporation04 Sep 2009
Launch Date04 Sep 2009
Address23rd Floor, One Lodha Place,S. B. Road, Lower Parel. Mumbai 400013
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,